Advances in Heparins and Related Research. An Epilogue.
نویسندگان
چکیده
The discovery of heparin in 1916 by Jay McLean, a medical student at Johns Hopkins University, not only provided a universal anticoagulant, but also laid the foundation for the discipline of hemostasis and thrombosis[...].
منابع مشابه
EPILOGUE: From Introspections, Brain Scans, and Memory Tests to the Role of Social Context: Advancing Research on Interaction and Learning
The goal of this epilogue is to use the methodological contributions of the studies presented in this special issue as a starting point for suggestions about methodology in conducting future interaction research+ As is the case in most developing fields, interaction research develops methods internally as it continually borrows and extends techniques used in other disciplines and revitalizes ol...
متن کاملFuture advances in the early detection of reading risk: Subgroups, dynamic relations, and advanced methodologies: Epilogue to Journal of Learning Disabilities Special Edition â•œAdvances in the Early Detection of Reading Riskâ•š
متن کامل
Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity.
PURPOSE Unfractionated heparin reduces metastasis in many murine models. Multiple mechanisms are proposed, particularly anticoagulation and/or inhibition of P-selectin and L-selectin. However, the doses used are not clinically tolerable and other heparins are now commonly used. We studied metastasis inhibition by clinically relevant levels of various heparins and investigated the structural bas...
متن کاملEpilogue: understanding children who have been affected by maltreatment and prenatal alcohol exposure: future directions.
This epilogue summarizes the six articles presented in the clinical forum focused on understanding children who have been affected by maltreatment and prenatal alcohol exposure. It presents common themes that emerged among the articles and future research directions.
متن کاملHigh plasma endostatin level unaffected by low-molecular weight heparin in hemodialysis patients--a preliminary report.
PURPOSE Endostatin (ES) is a potent inhibitor of angiogenesis and neoangiogenesis, and interestingly its activity is modified by heparin. To understand if low-molecular weight heparins have different clinical profiles regarding this cytokine, we studied the effects of enoxaparin, nadroparin and dalteparin administered for hemodialysis (HD) anticoagulation on plasma ES levels. MATERIAL AND MET...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Molecules
دوره 23 2 شماره
صفحات -
تاریخ انتشار 2018